Litcius/Paper detail

Arguments in favour of remdesivir for treating SARS-CoV-2 infections

Wen‐Chien Ko, Jean‐Marc Rolain, Nan–Yao Lee, Po‐Lin Chen, Ching-Tai Huang, Ping‐Ing Lee, Po‐Ren Hsueh

2020International Journal of Antimicrobial Agents328 citationsDOIOpen Access PDF

Topics & Concepts

CoronaviridaeBetacoronavirusCoronavirusPneumoniaMedicineVirologyAtypical pneumoniaDiseaseCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)Internal medicineSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing
Arguments in favour of remdesivir for treating SARS-CoV-2 infections | Litcius